David Radspinner spoke on November 14th at the 2016 edition of the Biomanufacturing World Summit. His session was entitled, A New Way to Rapidly Develop Biomanufacturing Capacity and Add Greater Value to the Decision to Build.
In March 2016, David Radspinner was appointed as the General Manager for the GEHC LS newly created BioPark business.
Previously, in January of 2014, GE acquired the HyClone Cell Culture business and subsequently David was appointed as its Hold Separate Manager.
David earned a PhD in Analytical Chemistry from the University of Arizona and has spent over 14 years working within the areas of developing, manufacturing and characterizing pharmaceuticals. David has over 10 years experience in business development, product management, sales, marketing and cross-functional leadership.